http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200617001-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59e1d955a7b1560dc68cf7fd800e8fac |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/E04F13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/F16B13-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/F16B13-10 |
| filingDate | 2005-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdf8b634b0dc32aa49250dec65e7a046 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39b7fa6d40d4bbb139d3e6e86d85a323 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_077830f1ba82f044d887aeeb3c726261 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea98be8db24c3983a65def03a3fbefc8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82d588e392db14bbe92ad73ca3786ef8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b61101eda743d1e21c83194a60e2e56 |
| publicationDate | 2006-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-200617001-A |
| titleOfInvention | Novel glucitol derivative, its prodrug, their salt and diabetic therapeutic agent containing the same |
| abstract | The object of the present invention is to provide glycositol derivatives which have blood sugar level lowering action and, in addition, suitable properties as drugs such as drug effect durability, metabolic stability and safety and to provide pharmaceutical compositions which are used for the prophylaxis or treatment of diabetes such as insulin-dependent diabetes (type I diabetes) and insulin-independent diabetes (type II diabetes), diabetic complications and diseases such as obesity caused by hyperglycemia. Compounds of formula (I), , (wherein m is an integer selected from 1 to 3; R1, R2, R3 and R4 are each independently selected from a hydrogen atom, a C1-C6 alkyl group which may be substituted, a C7-C14 aralkyl group which may be substituted and -C(=O)Rx; Ar1 is a naphthyl group which may be substituted; A is a heteroaryl group which may be substituted with one or more Rb and the heteroaryl group may form a fused ring with an aromatic carbon ring or an aromatic heterocycle, provided that when A is a benzo-fused ring containing two or more rings, the group -(CH2)m- is connected on to a heterocycle in (A) or a prodrug or a pharmaceutically acceptable salt thereof, and drugs and pharmaceutical compositions which contain the compounds are provided by the present invention. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I403516-B |
| priorityDate | 2004-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 110.